Zingales B, Pereira M E, Oliveira R P, Almeida K A, Umezawa E S, Souto R P, Vargas N, Cano M I, da Silveira J F, Nehme N S, Morel C M, Brener Z, Macedo A
Instituto de Química, Universidade de São Paulo, Brazil.
Acta Trop. 1997 Nov;68(2):159-73. doi: 10.1016/s0001-706x(97)00088-0.
Clone CL Brener is the reference organism used in the Trypanosoma cruzi Genome Project. CL Brener was obtained by cloning procedures from bloodstream trypomastigotes isolated from mice infected with the CL strain. The doubling time of CL Brener epimastigotes cultured at 28 degrees C in liver infusion-tryptose (LIT) medium is 58 +/- 13 h. Differentiation to metacyclic forms is induced by incubation of epimastigotes in LIT-20% Grace's medium. Metacyclics give very low parasitemia in mice, contrary to what is observed for blood forms which promote 100% mortality of the animals with inocula of 5 x 10(3) parasites. CL Brener blood forms are highly susceptible to nifurtimox, benznidazole and ketoconazole. Allopurinol is inefficient in the treatment of mice experimental infection. The clone infects mammalian cultured cells and performs the complete intracellular cycle at 33 and 37 degrees C. The molecular typing of CL Brener has been done by isoenzymatic profiles; sequencing of a 24S alpha ribosomal RNA gene domain and by schizodeme, randomly amplified polymorphic DNA and DNA fingerprinting analyses. For each typing approach the patterns obtained do not change after prolonged parasite subcultivation in LIT medium (up to 100 generations). The stability of the molecular karyotype of the clone was also confirmed.
克隆株CL Brener是克氏锥虫基因组计划中使用的参考生物体。CL Brener是通过克隆程序从感染CL株的小鼠体内分离出的血流型锥鞭毛体中获得的。CL Brener型前鞭毛体在28℃的肝浸液 - 胰蛋白胨(LIT)培养基中培养时的倍增时间为58±13小时。将前鞭毛体在LIT - 20%格雷斯培养基中孵育可诱导其分化为循环后期形式。与血行形式不同,循环后期形式在小鼠体内引起的寄生虫血症非常低,血行形式接种5×10³个寄生虫可导致100%的动物死亡。CL Brener血行形式对硝呋莫司、苯硝唑和酮康唑高度敏感。别嘌呤醇对小鼠实验性感染的治疗无效。该克隆株可感染哺乳动物培养细胞,并在33℃和37℃下完成完整的细胞内周期。CL Brener的分子分型已通过同工酶谱、24Sα核糖体RNA基因结构域测序以及裂殖体型、随机扩增多态性DNA和DNA指纹分析完成。对于每种分型方法,在LIT培养基中长时间传代培养寄生虫(多达100代)后,所获得的模式不会改变。该克隆株分子核型的稳定性也得到了证实。